검색결과 : 10건
| No. | Article |
|---|---|
| 1 |
The Wnt3a/beta-catenin/TCF7L2 signaling axis reduces the sensitivity of HER2-positive epithelial ovarian cancer to trastuzumab Shen GD, Gao Q, Liu FF, Zhang Y, Dai M, Zhao TT, Cheng M, Xu TJ, Jin PP, Yin W, Huang DB, Weng HY, Chen W, Ren HR, Mu XX, Wu XC, Hu SL Biochemical and Biophysical Research Communications, 526(3), 685, 2020 |
| 2 |
Synthesis of highly-specific stable nanocrystalline goethite-like hydrous ferric oxide nanoparticles for biomedical applications by simple precipitation method Lunin AV, Kolychev EL, Mochalova EN, Cherkasov VR, Nikitin MP Journal of Colloid and Interface Science, 541, 143, 2019 |
| 3 |
Gigantoxin-4-4D5 scFv is a novel recombinant immunotoxin with specific toxicity against HER2/neu-positive ovarian carcinoma cells Lv XX, Zhang J, Xu R, Dong YG, Sun AY, Shen YL, Wei DZ Applied Microbiology and Biotechnology, 100(14), 6403, 2016 |
| 4 |
In vitro incorporation of a cell-binding protein to a lentiviral vector using an engineered split intein enables targeted delivery of genetic cargo Chamoun-Emanuelli AM, Wright G, Roger S, Munch RC, Buchholz CJ, Chen ZL Biotechnology and Bioengineering, 112(12), 2611, 2015 |
| 5 |
Construction and characterization of a recombinant human beta defensin 2 fusion protein targeting the epidermal growth factor receptor: in vitro study Zhang MJ, Qiu ZW, Li YY, Yang Y, Zhang QH, Xiang Q, Su ZJ, Huang YD Applied Microbiology and Biotechnology, 97(9), 3913, 2013 |
| 6 |
Caleosin-assembled oil bodies as a potential delivery nanocarrier Chiang CJ, Lin SC, Lin LJ, Chen CJ, Chao YP Applied Microbiology and Biotechnology, 93(5), 1905, 2012 |
| 7 |
Engineering of Escherichia coli for Targeted Delivery of Transgenes to HER2/neu-Positive Tumor Cells Chang CH, Cheng WJ, Chen SY, Kao MC, Chiang CJ, Chao YP Biotechnology and Bioengineering, 108(7), 1662, 2011 |
| 8 |
Lysophospholipids transactivate HER2/neu (erbB-2) in human gastric cancer cells Shida D, Kitayama J, Yamaguchi H, Yamashita H, Mori K, Watanabe T, Nagawa H Biochemical and Biophysical Research Communications, 327(3), 907, 2005 |
| 9 |
EBNA1 may prolong G(2)/M phase and sensitize HER2/neu-overexpressing ovarian cancer cells to both topoisomerase II-targeting and paclitaxel drugs Chuang TC, Lee YJ, Liu JY, Lin YS, Li JW, Wang VC, Law SL, Kao MC Biochemical and Biophysical Research Communications, 307(3), 653, 2003 |
| 10 |
Recent progress in biomolecular engineering Ryu DDY, Nam DH Biotechnology Progress, 16(1), 2, 2000 |